ArticleAJPM focus2025
Medical Cannabis Utilization Across States With Varying Legal Status.
Article in AJPM focus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Real-world quality of life and sleep outcomes in patients treated with THC- and CBD-richFrontiers in pharmacology · 2026Article
- Impact of Healthcare Provider Awareness and Guidance on the Medical Cannabis Experience.Medical cannabis and cannabinoidsArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Despite increasing legalization of medical cannabis across the U.S., significant barriers to access and utilization remain, particularly in states with restrictive policies. This study aimed to explore the patterns of medical cannabis use, methods of acquisition, perceived efficacy, and barriers to use, with a focus on how these factors vary by state-level legal status. Methods: A cross-sectional, nationwide survey was administered online during August-September 2023 to a purposefully sampled U.S. adult population. Of 2,824 respondents, 996 individuals self-identified as using cannabis for medical purposes and were included in the final analysis. Measures included demographic variables, cannabis usage patterns, therapeutic indications, perceived effectiveness, and challenges related to legal frameworks and healthcare disclosure. Results: Cannabis use varied significantly by state legal status (chi-square=22.26, Conclusions: The findings highlight significant variations in medical cannabis usage and associated challenges based on state legal frameworks. Barriers such as cost and fear of disclosure underscore the need for clearer communication and policy reforms to improve access and patient-provider dialog. Further research is warranted to explore the clinical implications of medical cannabis use across diverse populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.